MNKD Q1 2018 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+15.2% YoY

Gross Profit

-$543,000-15.7% margin

Operating Income

-$27M-773.1% margin

Net Income

-$30M-876.9% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

-23.5%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$62M

Total Liabilities

$285M

Stockholders' Equity

-$223M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+15.2%
Gross Profit	-$543,000	$461,000	-217.8%
Operating Income	-$27M	-$20M	-36.7%
Net Income	-$30M	-$16M	-86.1%